Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

IBEX vs CNXC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IBEX
IBEX Limited

Information Technology Services

TechnologyNASDAQ • US
Market Cap$379M
5Y Perf.+41.3%
CNXC
Concentrix Corporation

Information Technology Services

TechnologyNASDAQ • US
Market Cap$1.67B
5Y Perf.-70.3%

IBEX vs CNXC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IBEX logoIBEX
CNXC logoCNXC
IndustryInformation Technology ServicesInformation Technology Services
Market Cap$379M$1.67B
Revenue (TTM)$627M$9.83B
Net Income (TTM)$47M$-1.28B
Gross Margin21.3%33.3%
Operating Margin9.2%6.2%
Forward P/E8.2x2.0x
Total Debt$70M$4.64B
Cash & Equiv.$15M$327M

IBEX vs CNXCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IBEX
CNXC
StockNov 20May 26Return
IBEX Limited (IBEX)100141.3+41.3%
Concentrix Corporat… (CNXC)10029.6-70.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: IBEX vs CNXC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IBEX leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Concentrix Corporation is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
IBEX
IBEX Limited
The Income Pick

IBEX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 2 yrs, beta 0.80
  • Rev growth 9.8%, EPS growth 28.3%, 3Y rev CAGR 4.2%
  • 82.5% 10Y total return vs CNXC's -63.2%
Best for: income & stability and growth exposure
CNXC
Concentrix Corporation
The Value Play

CNXC is the clearest fit if your priority is value and dividends.

  • Lower P/E (2.0x vs 8.2x)
  • 6.0% yield; 5-year raise streak; the other pay no meaningful dividend
Best for: value and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthIBEX logoIBEX9.8% revenue growth vs CNXC's 2.2%
ValueCNXC logoCNXCLower P/E (2.0x vs 8.2x)
Quality / MarginsIBEX logoIBEX7.5% margin vs CNXC's -13.0%
Stability / SafetyIBEX logoIBEXBeta 0.80 vs CNXC's 1.38, lower leverage
DividendsCNXC logoCNXC6.0% yield; 5-year raise streak; the other pay no meaningful dividend
Momentum (1Y)IBEX logoIBEX+8.7% vs CNXC's -50.0%
Efficiency (ROA)IBEX logoIBEX16.4% ROA vs CNXC's -10.8%, ROIC 19.5% vs 5.6%

IBEX vs CNXC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IBEXIBEX Limited

Segment breakdown not available.

CNXCConcentrix Corporation
FY 2025
Reportable Segment
100.0%$9.8B

IBEX vs CNXC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIBEXLAGGINGCNXC

Income & Cash Flow (Last 12 Months)

IBEX leads this category, winning 4 of 6 comparable metrics.

CNXC is the larger business by revenue, generating $9.8B annually — 15.7x IBEX's $627M. IBEX is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to CNXC's -13.0%. On growth, IBEX holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIBEX logoIBEXIBEX LimitedCNXC logoCNXCConcentrix Corpor…
RevenueTrailing 12 months$627M$9.8B
EBITDAEarnings before interest/tax$76M$773M
Net IncomeAfter-tax profit$47M-$1.3B
Free Cash FlowCash after capex$32M$572M
Gross MarginGross profit ÷ Revenue+21.3%+33.3%
Operating MarginEBIT ÷ Revenue+9.2%+6.2%
Net MarginNet income ÷ Revenue+7.5%-13.0%
FCF MarginFCF ÷ Revenue+5.2%+5.8%
Rev. Growth (YoY)Latest quarter vs prior year+16.8%+4.3%
EPS Growth (YoY)Latest quarter vs prior year+21.9%-14.9%
IBEX leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CNXC leads this category, winning 6 of 6 comparable metrics.

On an enterprise value basis, CNXC's 4.7x EV/EBITDA is more attractive than IBEX's 6.8x.

MetricIBEX logoIBEXIBEX LimitedCNXC logoCNXCConcentrix Corpor…
Market CapShares × price$379M$1.7B
Enterprise ValueMkt cap + debt − cash$433M$6.0B
Trailing P/EPrice ÷ TTM EPS11.91x-1.17x
Forward P/EPrice ÷ next-FY EPS est.8.23x2.03x
PEG RatioP/E ÷ EPS growth rate0.30x
EV / EBITDAEnterprise value multiple6.78x4.75x
Price / SalesMarket cap ÷ Revenue0.68x0.17x
Price / BookPrice ÷ Book value/share3.29x0.54x
Price / FCFMarket cap ÷ FCF13.87x2.91x
CNXC leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

IBEX leads this category, winning 9 of 9 comparable metrics.

IBEX delivers a 31.8% return on equity — every $100 of shareholder capital generates $32 in annual profit, vs $-33 for CNXC. IBEX carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNXC's 1.69x. On the Piotroski fundamental quality scale (0–9), IBEX scores 7/9 vs CNXC's 5/9, reflecting strong financial health.

MetricIBEX logoIBEXIBEX LimitedCNXC logoCNXCConcentrix Corpor…
ROE (TTM)Return on equity+31.8%-33.2%
ROA (TTM)Return on assets+16.4%-10.8%
ROICReturn on invested capital+19.5%+5.6%
ROCEReturn on capital employed+22.4%+6.6%
Piotroski ScoreFundamental quality 0–975
Debt / EquityFinancial leverage0.52x1.69x
Net DebtTotal debt minus cash$54M$4.3B
Cash & Equiv.Liquid assets$15M$327M
Total DebtShort + long-term debt$70M$4.6B
Interest CoverageEBIT ÷ Interest expense62.30x-3.07x
IBEX leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

IBEX leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in IBEX five years ago would be worth $11,977 today (with dividends reinvested), compared to $1,899 for CNXC. Over the past 12 months, IBEX leads with a +8.7% total return vs CNXC's -50.0%. The 3-year compound annual growth rate (CAGR) favors IBEX at 14.6% vs CNXC's -31.4% — a key indicator of consistent wealth creation.

MetricIBEX logoIBEXIBEX LimitedCNXC logoCNXCConcentrix Corpor…
YTD ReturnYear-to-date-22.6%-40.7%
1-Year ReturnPast 12 months+8.7%-50.0%
3-Year ReturnCumulative with dividends+50.4%-67.8%
5-Year ReturnCumulative with dividends+19.8%-81.0%
10-Year ReturnCumulative with dividends+82.5%-63.2%
CAGR (3Y)Annualised 3-year return+14.6%-31.4%
IBEX leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

IBEX leads this category, winning 2 of 2 comparable metrics.

IBEX is the less volatile stock with a 0.80 beta — it tends to amplify market swings less than CNXC's 1.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IBEX currently trades 65.4% from its 52-week high vs CNXC's 38.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIBEX logoIBEXIBEX LimitedCNXC logoCNXCConcentrix Corpor…
Beta (5Y)Sensitivity to S&P 5000.80x1.38x
52-Week HighHighest price in past year$42.99$62.14
52-Week LowLowest price in past year$24.53$22.85
% of 52W HighCurrent price vs 52-week peak+65.4%+38.2%
RSI (14)Momentum oscillator 0–10050.536.5
Avg Volume (50D)Average daily shares traded114K1.6M
IBEX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CNXC leads this category, winning 1 of 1 comparable metric.

Wall Street rates IBEX as "Hold" and CNXC as "Buy". Consensus price targets imply 119.2% upside for CNXC (target: $52) vs -14.6% for IBEX (target: $24). CNXC is the only dividend payer here at 6.00% yield — a key consideration for income-focused portfolios.

MetricIBEX logoIBEXIBEX LimitedCNXC logoCNXCConcentrix Corpor…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$24.00$52.00
# AnalystsCovering analysts69
Dividend YieldAnnual dividend ÷ price+6.0%
Dividend StreakConsecutive years of raises25
Dividend / ShareAnnual DPS$1.42
Buyback YieldShare repurchases ÷ mkt cap+20.6%+11.3%
CNXC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

IBEX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNXC leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallIBEX Limited (IBEX)Leads 4 of 6 categories
Loading custom metrics...

IBEX vs CNXC: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is IBEX or CNXC a better buy right now?

For growth investors, IBEX Limited (IBEX) is the stronger pick with 9.

8% revenue growth year-over-year, versus 2. 2% for Concentrix Corporation (CNXC). IBEX Limited (IBEX) offers the better valuation at 11. 9x trailing P/E (8. 2x forward), making it the more compelling value choice. Analysts rate Concentrix Corporation (CNXC) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IBEX or CNXC?

On forward P/E, Concentrix Corporation is actually cheaper at 2.

0x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — IBEX or CNXC?

Over the past 5 years, IBEX Limited (IBEX) delivered a total return of +19.

8%, compared to -81. 0% for Concentrix Corporation (CNXC). Over 10 years, the gap is even starker: IBEX returned +82. 5% versus CNXC's -63. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IBEX or CNXC?

By beta (market sensitivity over 5 years), IBEX Limited (IBEX) is the lower-risk stock at 0.

80β versus Concentrix Corporation's 1. 38β — meaning CNXC is approximately 73% more volatile than IBEX relative to the S&P 500. On balance sheet safety, IBEX Limited (IBEX) carries a lower debt/equity ratio of 52% versus 169% for Concentrix Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — IBEX or CNXC?

By revenue growth (latest reported year), IBEX Limited (IBEX) is pulling ahead at 9.

8% versus 2. 2% for Concentrix Corporation (CNXC). On earnings-per-share growth, the picture is similar: IBEX Limited grew EPS 28. 3% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IBEX or CNXC?

IBEX Limited (IBEX) is the more profitable company, earning 6.

6% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IBEX leads at 8. 3% versus 6. 2% for CNXC. At the gross margin level — before operating expenses — CNXC leads at 35. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IBEX or CNXC more undervalued right now?

On forward earnings alone, Concentrix Corporation (CNXC) trades at 2.

0x forward P/E versus 8. 2x for IBEX Limited — 6. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNXC: 119. 2% to $52. 00.

08

Which pays a better dividend — IBEX or CNXC?

In this comparison, CNXC (6.

0% yield) pays a dividend. IBEX does not pay a meaningful dividend and should not be held primarily for income.

09

Is IBEX or CNXC better for a retirement portfolio?

For long-horizon retirement investors, IBEX Limited (IBEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

80)). Both have compounded well over 10 years (IBEX: +82. 5%, CNXC: -63. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IBEX and CNXC?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IBEX is a small-cap deep-value stock; CNXC is a small-cap income-oriented stock. CNXC pays a dividend while IBEX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

IBEX

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 5%
Run This Screen
Stocks Like

CNXC

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Gross Margin > 19%
  • Dividend Yield > 2.3%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IBEX and CNXC on the metrics below

Revenue Growth>
%
(IBEX: 16.8% · CNXC: 4.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.